Dr. Shawn Hauser, Cannabis Legislative and Policy Update

February 2023

Ms. Shawn Hauser is a partner at Vicente Sederberg and co-chair of the firm’s Hemp and Cannabinoids Department as well as a leader in the firm’s psychedelics and emerging therapies practice. Shawn helps cannabis, hemp, and psychedelics businesses navigate the intersections between state and federal law including cannabis and psychedelics laws and food and drug laws as they evolve. Her practice includes regulatory compliance, licensing, general business representation, investment, policy reform and strategic guidance to best position businesses for success at the at state, national, and international levels.

Shawn has presented cannabis law and policy to many local, federal, and international agencies, including the Food and Drug Administration and UK Parliament. She is on the Board of Directors of the International Cannabis Bar Association, and was on the steering committee for the American Hemp Campaign, a project of Vote Hemp which was instrumental in legalizing hemp in Texas in 2019. In 2023, Shawn was recognized by her peers in the “Best Lawyers” list for her work in cannabis law.

Since directing Sensible Colorado’s local government implementation team following the passage of Amendment 64, Shawn remains active in policy work with local and state governments in Colorado and Texas and is passionate in supporting the development and implementation of cannabis, hemp, and psychedelics regulations that advance the cannabis industry in a dynamic and responsible manner. After attending law school at the University of Denver, Shawn was an associate attorney at McAllister, Darnell & Gottlieb PC, one of the first marijuana-focused law firms in Colorado.

Previous Webinars

Andrew Maxwell Phineas Jones, PhD

July 15th @ 11:00AM MT

Ten years of Cannabis micropropagation: What has changed and what are the best uses

 Dr. A.M.P. (Max) Jones is a professor and leading researcher in cannabis biotechnology at the University of Guelph, Canada. For the last decade his research has focused on plant tissue culture and micropropagation systems for cannabis and in 2018 his lab […]

Read More »

Tony P. George, MD, FRCPC

June 11, 2026 at 1 PM MDT

Understanding the links between cannabis use and mental illness: Implications for treatment

 

Dr. George is Professor of Psychiatry in the Temerty Faculty of Medicine at the University of Toronto (UofT), and Senior Scientist at the Centre for Addiction and Mental Health (CAMH). He received his B.Sc. (1988) and M.D. (1992) degrees from […]

Read More »

Jacob MacWilliams, Ph.D.

May 20, 2026 11:00AM MDT

Unlocking the mystery of a key hemp pest, cannabis aphid

Dr. Jacob MacWilliams is a research scientist in Dr. Punya Nachappa’s lab in the Agricultural Biology Department at Colorado State University. Jacob received his Ph.D. in Biochemistry and Molecular Biology at the University of California, Riverside focusing on cowpea aphid resistance in […]

Read More »

Shanna Bablonis, Ph.D.

Cannabis and Opioid Interactions: Human Laboratory Studies and Clinical Implications

May 14, 2026 1:00PM MDT

Shanna Babalonis, PhD is an associate professor in the University of Kentucky (UK) College of Medicine Department of Behavioral Science and Center on Drug and Alcohol Research. Her NIH-funded research focuses on clinical trials and human laboratory assessments of the abuse potential, […]

Read More »

Michael Petersen

Apr 15, 2026 11:00 AM Mountain Time

Trait Modifications in Cannabis Through Engineering and Editing

Michael Petersen has over 40 years of experience as a researcher and mentor in the plant biotech space. He worked for 10 years at Agracetus, a small startup in Wisconsin and then 20 years as a Senior Fellow with Monsanto. Mike stayed […]

Read More »